The European Patent Office (EPO) has published patent application EP2026030605A1, which describes novel methods for the extraction and detection of RNA from urine samples. The application, published on March 18, 2026, falls under the C12N classification for biotechnology and includes inventors and designated states across Europe.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. Companies operating in the biotechnology and diagnostics sectors may wish to review the patent details for potential intellectual property insights or competitive intelligence. No compliance actions or deadlines are associated with this patent publication itself.